DYAI

What one share of Dyadic International holds

Biological Products, (No Diagnostic Substances)

International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”), doing business as Dyadic Applied BioSolutions, is a global biotechnology company based in Jupiter, Florida, with operations in the United

Dyadic International’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$0.11
Profit−$0.21
Cash and investments$0.04
Book value−$0.07

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2017$0.03−$0.07———$1.76
2018$0.05−$0.21———$1.59
2019$0.06−$0.31———$1.31
2020$0.06−$0.34———$1.03
2021$0.09−$0.47———$0.65
2022$0.10−$0.34———$0.39
2023$0.10−$0.24———$0.20
2024$0.12−$0.20———$0.08
2025$0.09−$0.23———$0.03

Common questions about Dyadic International

How much does one share of Dyadic International earn?

Over the last 12 months, Dyadic International lost $0.21 for each share on $0.11 of sales.

Does Dyadic International pay a dividend?

Dyadic International didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Dyadic International’s book value per share?

Dyadic International’s book value is negative (−$0.07 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.

How much cash and debt does each share of Dyadic International have?

Each share of Dyadic International has $0.04 of cash and investments, as of June 30, 2026.

Has Dyadic International bought back shares?

Dyadic International’s share count rose about 13% from 2017 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.